Mass spectroscopy identifies the splicing-associated proteins, PSF, hnRNP H3, hnRNP A2/B1, and TLS/FUS as interacting partners of the ZNF198 protein associated with rearrangement in myeloproliferative disease.

ZNF198 is fused with FGFR1 in an atypical myeloproliferative disease that results in constitutive activation of the kinase domain and mislocalization to the cytoplasm. We have used immunoprecipitation of a GFP-tagged ZNF198 combined with MALDI-TOF mass spectroscopy to identify interacting proteins. P splicing factor (PSF) was identified as one of the proteins and this interaction was confirmed by Western blotting. Other proteins identified were the spliceosomal components hnRNP A2/B1, hnRNP H3, and TLS/FUS. PSF is also known to interact with PTB, another member of the hnRNP family of proteins, and we further demonstrated that PTB interacts with ZNF198. The interaction between TLS/FUS and ZNF198 was confirmed using Western blot analysis. In 293 cells expressing the ZNF198/FGFR1 fusion protein, neither PSF nor PTB binds to the fusion protein, possibly because of their differential localization in the cell.

[1]  D. Birnbaum,et al.  Characterization of FIM-FGFR1, the Fusion Product of the Myeloproliferative Disorder-associated t(8;13) Translocation* , 1999, The Journal of Biological Chemistry.

[2]  T. Nilsen.  The spliceosome: the most complex macromolecular machine in the cell? , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  R. Hannan,et al.  Transcription by RNA polymerase I. , 1998, Frontiers in bioscience : a journal and virtual library.

[4]  T. Hudson,et al.  FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome , 1998, Nature Genetics.

[5]  G. Dreyfuss,et al.  Messenger-RNA-binding proteins and the messages they carry , 2002, Nature Reviews Molecular Cell Biology.

[6]  J. G. Patton,et al.  An RNA recognition motif (RRM) is required for the localization of PTB-associated splicing factor (PSF) to subnuclear speckles. , 2001, Experimental cell research.

[7]  J. Cowell,et al.  The Oncogenic Fusion Protein-tyrosine Kinase ZNF198/Fibroblast Growth Factor Receptor-1 Has Signaling Function Comparable with Interleukin-6 Cytokine Receptors* , 2003, The Journal of Biological Chemistry.

[8]  J. G. Patton,et al.  A novel set of spliceosome‐associated proteins and the essential splicing factor PSF bind stably to pre‐mRNA prior to catalytic step II of the splicing reaction. , 1994, The EMBO journal.

[9]  Melissa S Jurica,et al.  Pre-mRNA splicing: awash in a sea of proteins. , 2003, Molecular cell.

[10]  S. Tsai,et al.  Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA Splicing* , 1998, The Journal of Biological Chemistry.

[11]  Steven P. Gygi,et al.  Comprehensive proteomic analysis of the human spliceosome , 2002, Nature.

[12]  M. Mann,et al.  Large-scale Proteomic Analysis of the Human Spliceosome References , 2006 .

[13]  D. Smedley,et al.  The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. , 1998, Human molecular genetics.

[14]  L. Embree,et al.  TLS-ERG Leukemia Fusion Protein Inhibits RNA Splicing Mediated by Serine-Arginine Proteins , 2000, Molecular and Cellular Biology.

[15]  G. Varani,et al.  RNA recognition by RNP proteins during RNA processing. , 1998, Annual review of biophysics and biomolecular structure.

[16]  S. Chin,et al.  ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. , 2006, Experimental cell research.

[17]  J. Cowell,et al.  ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins , 2003, Oncogene.

[18]  J. Cowell,et al.  The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. , 1998, Blood.

[19]  T. Misteli.  The concept of self-organization in cellular architecture , 2001, The Journal of cell biology.

[20]  M. Mann,et al.  Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. , 1995, RNA.

[21]  M. Mann,et al.  Directed Proteomic Analysis of the Human Nucleolus , 2002, Current Biology.

[22]  L. Hawthorn,et al.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. , 2006, Blood.

[23]  R. Tjian,et al.  Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis. , 1988, Science.

[24]  R. Foisner,et al.  Differential nuclear localization and nuclear matrix association of the splicing factors PSF and PTB , 2000, Journal of cellular biochemistry.

[25]  D. Immanuel,et al.  A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited , 1997, Oncogene.

[26]  J. G. Patton,et al.  Cloning and characterization of PSF, a novel pre-mRNA splicing factor. , 1993, Genes & development.